United States: Impact Of Nautilus On Biotech And Pharmaceutical Patents

Last Updated: November 23 2015
Article by Zhiqiang Liu and Eugene M. Gelernter

In Nautilus, Inc. v. Biosig Instruments, Inc., 134 S. Ct. 2120 (2014), the Supreme Court rejected the Federal Circuit's "insolubly ambiguous" standard for determining whether a patent claim meets the definiteness requirement under 35 U.S.C. §112, ¶ 2, and held that "a patent is invalid for indefiniteness if its claims, read in light of the specification delineating the patent, and the prosecution history, fail to inform, with reasonable certainty, those skilled in the art about the scope of the invention." In the ensuing one and a half years, the Federal Circuit and several trial courts have applied the Nautilus standard in the biotechnology and pharmaceutical contexts. We discuss three notable decisions.

In Teva Pharms. USA, Inc. v. Sandoz, Inc., 789 F.3d 1335 (Fed. Cir. 2015), the Federal Circuit, on remand from the Supreme Court decision in Teva Pharms. USA, Inc. v. Sandoz, Inc., 135 S. Ct. 831 (2015), found a disputed patent claim indefinite in part based on conflicting representations made by the patentee during the prosecution of two related applications. The term was "molecular weight," or average molecular weight in the context of a synthetic copolymer. The concept of average molecular weight is also relevant to technologies concerning other macromolecules, such as proteins and DNA. Specifically, the Federal Circuit found that while average molecular weight can be ascertained by any of three possible measures, the claims do not indicate which measure to use, and the specification does not define molecular weight or mention any of the three measures. Additionally, the patentee argued conflicting positions during prosecution of two related patents containing identical disclosure, stating that one measure applies in one application and another applies in the other application. In light of the specification and the prosecution history of the related applications, the Federal Circuit held that the patentee failed to meet the reasonable certainty standard under Nautilus.

In Regeneron Pharms., Inc v. Merus B.V., 2014 U.S. Dist. LEXIS 163350 (S.D.N.Y. Nov. 21, 2014), the district court held a term in a patent related to genetic technologies indefinite because its metes and bounds cannot be determined with reasonable certainty. The patent relates to a mouse genetically modified to include human DNA at specific locations of a mouse chromosome. The disputed term was "endogenous mouse immunoglobulin locus." The court found it significant that the specification never used the disputed term, and never informed the reader how to find the immunoglobulin locus. While mentioning the use of structural or functional data to select a locus, the specification provided no specific data for locating the "endogenous mouse immunoglobulin locus." The court also found it relevant that the boundaries of the locus were unknown in the research community at the time of the patent filing. Finally, the court noted that one skilled in the art could not ascertain the scope of the invention because there is significant variation in the location of the locus among mice of different strains, and yet the specification lacks information as to the specific strains.

In Purdue Pharma L.P. v. Amneal Pharms., LLC (In re OxyContin Antitrust Litig.), 2015 U.S. Dist. LEXIS 45967 (S.D.N.Y. Apr. 8, 2015), the district court evaluated the question of definiteness based on whether the disputed term impacts the determination of infringement.  The court held a term indefinite because the patent did not tell one skilled in the art how to select a related parameter that impacts the results of the infringement analysis. The disputed term was "viscosity of at least about 60 cP." The court found that the patent permitted the use of a wide range of shear rates, and the choice of shear rate directly impacts the results of viscosity test and determines whether the accused product satisfies the viscosity limitation. Since the patent did not tell one skilled in the art how to select the shear rate, the court found the term indefinite for failing to meet the reasonable certainty standard.

However, the court declined to find the claims indefinite with respect to tampering temperature, testing temperature, or extent of dissolution. While acknowledging that the patent did not set forth precise guidance on these testing variables, the court held that the accused infringer had not shown that these variables impact whether an accused product infringes the patent; rather, the evidence shows that even when one skilled in the art fill the gaps in different ways, their choices do not produce conflicting results on infringement. The court noted Nautilus's suggestion that a claim is not ambiguous merely because readers “could reasonably interpret the claim’s scope differently.” The court concluded that despite the patent’s lack of specific direction on these variables, one skilled in the art could still discern, with reasonable certainty, the scope of the invention.

The decisions discussed above demonstrate the flexibility in the approaches courts have taken in making a definiteness determination. The Teva decision heavily relied on the prosecution history of related applications. The Purdue decision took a very practical approach and focused on whether the perceived uncertainty in the meaning of the disputed term ultimately created impermissible fuzziness concerning the scope of the invention.

These decisions also highlight the need for providing one-on-one support in the patent specification for the meaning of each term in the claim that does not have a clear ordinary meaning.  Particularly, both the Teva and Regeneron decisions found it significant that the specification did not address the disputed terms. It is important to define the relevant terms in the specification and ensure that the same terminology is used consistently in the specification and during prosecution.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions